Myomo, Inc. (MYO)
NYSEAMERICAN: MYO · Real-Time Price · USD
0.8340
+0.0115 (1.40%)
At close: Sep 17, 2025, 4:00 PM EDT
0.8204
-0.0136 (-1.63%)
After-hours: Sep 17, 2025, 4:52 PM EDT
Myomo Market Cap
Myomo has a market cap or net worth of $31.53 million as of September 17, 2025. Its market cap has decreased by -75.64% in one year.
Market Cap
31.53M
Enterprise Value
28.32M
1-Year Change
-75.64%
Ranking
Category
Stock Price
$0.83
Market Cap Chart
Since June 30, 2017, Myomo's market cap has decreased from $66.00M to $31.53M, a decrease of -52.23%. That is a compound annual growth rate of -8.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 31.10M | -84.03% |
| Dec 31, 2024 | 194.80M | 46.69% |
| Dec 29, 2023 | 132.80M | 3,588.89% |
| Dec 30, 2022 | 3.60M | -92.34% |
| Dec 31, 2021 | 47.00M | 52.60% |
| Dec 31, 2020 | 30.80M | 492.31% |
| Dec 31, 2019 | 5.20M | -70.95% |
| Dec 31, 2018 | 17.90M | -21.83% |
| Dec 29, 2017 | 22.90M | -65.30% |
| Jun 30, 2017 | 66.00M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |